Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.58/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.58), versus ($0.43) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor